Adjunctive Devices for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
Background: Coronary Heart Disease
Coronary heart disease (CHD) is a leading cause of morbidity and mortality in the United States. According to American Heart Association statistics, >650,000 deaths were attributed to CHD in 2003. Moreover, treatment costs for CHD represent the largest health care expenditure for a single disease in the United States. Acute coronary syndromes (ACSs), which include the clinical entities of unstable angina (UA), non–ST-segment elevation MI (NSTEMI), and ST-segment elevation MI (STEMI), account for more than 1.5 million hospital admissions annually in the United States alone. Approximately 1 million of these admissions are classified as UA/NSTEMI, and approximately 500,000 are STEMI.
Keywords: ACS | CHD | ST-segment elevation myocardial infarction | STEMI | acute coronary syndrome | coronary heart disease | cost | background
- Smith SC Jr, Feldman TE, Hirshfeld JW, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Assoc Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 2006;47:e1-121. PMID: 16386656. Available at www.ncbi.nlm.nih.gov/pubmed/16386656.
- Silber S, Albertsson P, Aviles FF, et al; Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Guidelines for percutaneous coronary intervention. Eur Heart J 2005;26:804-47. PMID: 15769784.
Your slide tray is being processed.